Home Featured Page 174

Featured

Latest

After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast

BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions

AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine...

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians...

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet...

Numinus Applies for International Patent Filing of Psychedelics Production Process

Small Pharma Reports Highlights for the Fiscal Year Ended February 28,...

Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and...

Mindmed Announces Voting Results for Annual General and Special Meeting

GH Research Reports First Quarter 2022 Financial Results and Provides Business...

COMPASS Pathways presents largest ever study of psilocybin therapy, at American...

Incannex announces positive results from phase 2 clinical trial investigating the...

EDITOR PICKS

After the Readout: How the Field Is Interpreting Compass’ Phase 3...

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

After the Readout: How the Field Is Interpreting Compass’ Phase 3 Psilocybin Data

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast

BREAKING: Second Positive Phase 3 for Compass’ Psilocybin, Though Modest Magnitude Raises Questions

AtaiBeckley Seeks Partner for BPL-003 as Pharma Interest Builds After AbbVie-Gilgamesh Deal

Revive Therapeutics Provides Update on Phase 3 Clinical Trial for Bucillamine...

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians...

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet...

Numinus Applies for International Patent Filing of Psychedelics Production Process

Small Pharma Reports Highlights for the Fiscal Year Ended February 28,...

Field Trip Health Ltd. Announces Increased Participation in Arrangement Financing and...

Mindmed Announces Voting Results for Annual General and Special Meeting

GH Research Reports First Quarter 2022 Financial Results and Provides Business...

COMPASS Pathways presents largest ever study of psilocybin therapy, at American...

Incannex announces positive results from phase 2 clinical trial investigating the...

EDITOR PICKS

After the Readout: How the Field Is Interpreting Compass’ Phase 3...

Q1’26 Psychedelic Drug Development Pipeline: Bullseye Charts

Compass Provides Fuller Phase 3 Picture, MADRS Curves, on Webcast

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY